or Try an Advanced Search...

    Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    AGEN D Agenus Inc. -7.26
    GNLX F Genelux Corporation -4.95
    ADAP D Adaptimmune Therapeutics plc -4.35
    NXTC D NextCure, Inc. -4.24
    APLM F Apollomics Inc. -4.14
    LCTX C Lineage Cell Therapeutics, Inc. -3.08
    PPBT F Purple Biotech Ltd. -2.93
    BCAB C BioAtla, Inc. -2.52
    TIL D Instil Bio, Inc. -2.51
    XOMA C XOMA Corporation -2.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Cancer Clinical Medicine Medicine Biopharmaceutical Small Cell Lung Cancer Immunotherapy Melanoma Cancer Immunotherapy Cancer Treatment Osteoarthritis Ovarian Cancer Solid Tumors Tumor Virotherapy Antineoplastic Drugs Biotechnology Cell Therapy Cervical Cancer Experimental Cancer Treatments Hypertension

    Related ETFs - A few ETFs which own one or more of the above listed Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    FORH B Formidable ETF 1.34
    CNCR D Loncar Cancer Immunotherapy ETF 0.69
    IWC C iShares Microcap ETF 0.21
    INNO D Harbor Disruptive Innovation ETF 0.2
    BTEC C Principal Healthcare Innovators Index ETF 0.09
    View all Non Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare CNCR to INNO Compare CNCR to IWC Compare INNO to BTEC

        Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        May 7 AGEN Agenus (AGEN) Q1 2024 Earnings Call Transcript
        May 7 AGEN Agenus Inc. (AGEN) Q1 2024 Earnings Call Transcript
        May 7 XOMA Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
        May 7 AGEN Agenus (AGEN) Reports Q1 Loss, Misses Revenue Estimates
        May 7 AGEN Agenus Inc (AGEN) Q1 2024 Earnings: Misses Revenue and EPS Estimates Amid Strategic Developments
        May 7 BCAB BioAtla to Announce First Quarter 2024 Financial Results and Provide Business Highlights on May 14, 2024
        May 7 AGEN Agenus GAAP EPS of -$3.04 beats by $0.18, revenue of $28M misses by $19.17M
        May 7 AGEN Agenus Reports First Quarter 2024 Results
        May 7 AGEN Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
        May 6 AGEN Agenus Q1 2024 Earnings Preview
        May 6 BCAB BioAtla announces FDA clearance of ind application for its treatment of multiple tumors
        May 6 BCAB BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors
        May 6 LCTX OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
        May 5 GNLX Genelux Corporation's (NASDAQ:GNLX) market cap rose US$11m last week; individual investors who hold 54% profited and so did insiders
        May 2 NXTC NextCure GAAP EPS of -$0.61 misses by $0.15
        May 2 NXTC NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
        May 2 BCAB BioAtla: A Buried ADC Concern Gets Some New Life In 2024
        May 2 LCTX Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
        May 1 ADAP Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024
        May 1 AGEN Agenus regains compliance with Nasdaq minimum bid price requirement
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Cancer Clinical Medicine Medicine Biopharmaceutical Small Cell Lung Cancer Immunotherapy Melanoma Cancer Immunotherapy Cancer Treatment Osteoarthritis Ovarian Cancer Solid Tumors Tumor Virotherapy Antineoplastic Drugs Biotechnology Cell Therapy Cervical Cancer Experimental Cancer Treatments Hypertension
        Non Small Cell Lung Cancer

        Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. It is a type of cancer that begins in the cells that line the airways of the lungs. NSCLC is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Symptoms of NSCLC include a persistent cough, chest pain, shortness of breath, and coughing up blood. Treatment options for NSCLC include surgery, chemotherapy, radiation therapy, and targeted therapy.

        Browse All Tags